InvestorsHub Logo
Followers 44
Posts 864
Boards Moderated 0
Alias Born 03/08/2014

Re: BlueJordan post# 257131

Thursday, 12/26/2019 11:28:41 PM

Thursday, December 26, 2019 11:28:41 PM

Post# of 700676
"Quite optimistic that TLD will change the situation for them....." is quite telling. LP/management have a phalanx of advisors...SAB, PIs, professional statisticians, etc. and accordingly, have much more data and interpretive understanding than anyone on the outside. With this aggregate team, a veritable virtual NWBO, they are the experts in immunological approaches and know more than anyone including the RAs. NWBO et al are the teachers with the amount of experience and knowledge gained in conducting this long standing trial that has been adaptive throughout its tenure. Badly architected trial? No, I don't think so. Prescient, yes, as it is adaptive knowing all along that time and developments have their impacts and NWBO slogged it through resulting in its crowning SAP, a truly ginormous task, which is completed with their satisfaction.

If what you report is fact, and I have no reason to doubt you, DI's statement is a hint if not over the top.
Quite the opposite of pessimistic, I'd say.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News